Dublin, Aug. 17, 2026 (GLOBE NEWSWIRE)-- The "XEOMIN Sales Forecast and Market Size Analysis - 2034" has been added to ResearchAndMarkets.com's offering. The "XEOMIN Sales Forecast and Market Size ...
(MENAFN- GlobeNewsWire - Nasdaq) XEOMIN can capitalize on demand for minimally invasive aesthetics, its protein-free formulation, broader facial and therapeutic indications, repeat-use potential, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results